Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethyl ferulate protects against lipopolysaccharide-induced acute lung injury by activating AMPK/Nrf2 signaling pathway.

Acta pharmacologica Sinica·2021
Same author

Unsupervised Estimation of Monocular Depth and VO in Dynamic Environments via Hybrid Masks.

IEEE transactions on neural networks and learning systems·2021
Same author

β-Caryophyllene attenuates lipopolysaccharide-induced acute lung injury via inhibition of the MAPK signalling pathway.

The Journal of pharmacy and pharmacology·2021
Same author

Robotic Gastrectomy Versus Laparoscopic Gastrectomy for Gastric Cancer: A Multicenter Cohort Study of 5402 Patients in China.

Annals of surgery·2021
Same author

Allergen-Specific Treg Cells Upregulated by Lung-Stage <i>S. japonicum</i> Infection Alleviates Allergic Airway Inflammation.

Frontiers in cell and developmental biology·2021
Same author

Dhx15 regulates zebrafish definitive hematopoiesis through the unfolded protein response pathway.

Cancer science·2021
Same journal

Nanotechnology-Stem Cell Strategies in 3D Glioblastoma Organoid: Targeting Glioma Stem Cells Within a Complex Tumor Microenvironment.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

ArrayTrack: an FDA and public genomic tool.

Hong Fang1, Stephen C Harris, Zhenjiang Su

  • 1Z-Tech Corporation, ICF International Company, Jefferson, AR, USA.

Methods in Molecular Biology (Clifton, N.J.)
|July 15, 2009
PubMed
Summary
This summary is machine-generated.

ArrayTrack is a specialized software platform developed by the FDA to help researchers manage, analyze, and interpret complex genomic data. It integrates gene expression information with biological pathways to support the evaluation of toxicological studies. The tool is publicly accessible and serves both regulatory review and independent scientific research.

Keywords:
bioinformatics softwaremicroarray analysisdata integrationregulatory review

Frequently Asked Questions

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Related Experiment Videos

Last Updated: Jun 21, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Area of Science:

  • Toxicogenomics research within ArrayTrack bioinformatics software development
  • Computational biology and data management systems

Background:

The field of toxicogenomics faces significant hurdles regarding the effective management of high-throughput biological datasets. Researchers often struggle to integrate diverse omics information into a cohesive framework for meaningful interpretation. Prior work has highlighted that robust computational infrastructure remains a primary requirement for advancing predictive toxicology. That uncertainty drove the development of specialized platforms designed to handle massive data volumes. It was already known that DNA microarrays generate complex outputs requiring sophisticated processing pipelines. This gap motivated the creation of systems capable of linking raw experimental results with established functional annotations. No prior work had resolved the need for a unified interface that bridges regulatory review requirements with public scientific accessibility. The current landscape demands tools that simplify the transition from raw data to biological understanding.

Purpose Of The Study:

The aim of this project is to develop a public microarray data management and analysis software platform. This initiative addresses the need for robust bioinformatics capabilities in the field of toxicogenomics. The researchers sought to create a system that simplifies the interpretation of massive amounts of experimental data. A primary motivation was to provide a tool that supports both regulatory review and independent scientific research. The team focused on integrating functional information from public databases with raw genomic results. They aimed to bridge the gap between data storage and meaningful biological insight. This work addresses the challenge of managing diverse omics information, including proteomics and metabonomics, within a single framework. The authors intended to provide a publicly accessible resource that enhances the reliability of toxicological studies.

Main Methods:

Review Approach framing involves describing the development of a public software platform for managing and analyzing microarray information. The design focuses on creating an integrated environment that links raw experimental outputs with functional biological annotations. Developers utilized various public databases to populate the system with comprehensive gene, protein, and pathway information. The approach emphasizes the consolidation of diverse data streams, including proteomics and metabonomics, into a single repository. Researchers implemented a toolbox containing multiple visualization and statistical analysis modules for user interaction. The system architecture supports both individual platform investigations and complex multi-omics integration tasks. This methodology ensures that clinical and non-clinical study data are stored alongside their corresponding genomic results. The project team provides both online access and local installation options to accommodate diverse user requirements.

Main Results:

Key Findings From the Literature indicate that the software successfully integrates gene expression data with functional information to streamline interpretation. The platform supports the storage of a full range of information related to DNA microarrays. It also manages digested data derived from proteomics and metabonomics experiments. Users can select from a rich collection of analysis methods within the software toolbox. The system facilitates the direct linking of analysis results to individual gene, pathway, and Gene Ontology information. This integration simplifies the overall process of data analysis and interpretation for researchers. The tool is currently employed in the routine review of genomic data submitted to the FDA. Public availability is maintained through an online portal, ensuring widespread access to these bioinformatics capabilities.

Conclusions:

Synthesis and Implications suggest that ArrayTrack provides a unified environment for managing diverse omics datasets. The authors propose that integrating functional annotations directly with experimental results simplifies complex data interpretation workflows. This platform facilitates the routine review of genomic submissions while remaining accessible to the broader scientific community. Researchers can link analytical outcomes to specific biological pathways and gene ontologies through this integrated system. The tool supports the storage and processing of proteomics and metabonomics information alongside standard microarray data. By providing a comprehensive toolbox, the software enhances the ability of users to perform multi-omics integration. The authors indicate that this infrastructure supports both clinical and non-clinical study requirements effectively. These capabilities demonstrate how centralized software resources can bridge the gap between raw data generation and actionable toxicological knowledge.

The researchers propose that the software simplifies interpretation by linking gene expression data directly to functional pathways and Gene Ontology analysis. This integration allows users to move seamlessly from raw experimental results to biological context, which is often difficult when using disparate, non-integrated analysis platforms.

ArrayTrack functions as a comprehensive management and analysis suite. It stores information from DNA microarrays, proteomics, and metabonomics experiments while providing a rich collection of functional annotations drawn from various public biological databases for facilitating data interpretation across different study types.

A local installation version is available for users who require it. The authors state that prospective users can obtain this version by contacting the NCTR directly, which is necessary for those needing to manage sensitive data or perform offline processing tasks.

The software integrates gene expression data, functional information, and analysis methods into one system. This role ensures that users can select specific tools from a toolbox and apply them to microarray datasets without needing to switch between different software environments for interpretation.

Users can perform individual platform data analysis, integrate multiple omics datasets, and combine omics results with clinical or non-clinical study information. This measurement capability allows for a more holistic view of toxicological impacts compared to analyzing single-omics datasets in isolation.

The authors claim that this software is used in the routine review of genomic data submitted to the FDA. They suggest that this public availability helps standardize the evaluation of toxicological studies, benefiting both regulatory bodies and the wider scientific community.